James A. Neubrander, M.D., F.A.A.E.M., joined ALS Worldwide on January 2, 2017 as our new Medical Director, bringing excellent skills, knowledge and more than 25 years of experience to our organization. He received his medical degree from Loma Linda University School of Medicine in California in 1975.
Dr. Neubrander is often referred to as “The Father of Methyl-B12” due to his pioneering work showing its profound effect on autism and other neurological disorders. As a Fellow of the American Academy of Environmental Medicine, Dr. Neubrander is uniquely qualified to share insights and awareness with the entire ALS Worldwide community.
Stephen and Barbara Byer, Co-Executive Directors of ALS Worldwide, originally met Dr. Neubrander in 2008, while exploring the benefits of the methylcobalamin form of B12 injections for the ALS patient community. Prior to 2003 methylcobalamin (methyl-B12) was rarely heard of as an effective treatment option for neurological diseases, nor was it commonly found in supplements. That all changed after Dr. Neubrander gave his first lecture about the powerful clinical benefits of methyl-B12 at the Defeat Autism Now! Conference in Philadelphia, May 2003.
Since that point in time methyl-B12 has become one of the most commonly used treatments for autism and ALS and is a common ingredient in many supplements. Though Dr. Neubrander’s practice focuses on autism, where he has become a beacon of light for parents of autistic children suffering from this devastating neurological disease, his current interest also focuses on ALS due to what he describes as their ‘profound similarities’. Dr. Neubrander’s autism treatments increase healing and repair, and he believes that these approaches have the potential to decrease the speed of decline for ALS patients while at the same time improving quality of life.